Argatroban administration as therapy for thrombosis in patients with continuous-flow ventricular assist devices

BACKGROUND: Device thrombosis is one of the main complications in left ventricular assist devices (LVAD) therapy and remains a challenging issue. Data on device thrombosis management, especially on the application of direct thrombin inhibitors such as argatroban, is limited and a consensus on thromb...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Thorac Dis
Egile Nagusiak: Wert, Leonhard, Hanke, Jasmin S., Dogan, Günes, Ricklefs, Marcel, Chatterjee, Anamika, Feldmann, Christina, Ismail, Issam, Napp, L. Christian, Haverich, Axel, Schmitto, Jan D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2018
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6035951/
https://ncbi.nlm.nih.gov/pubmed/30034844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.10.164
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak